Morton S. Kahlenberg

6.2k total citations · 3 hit papers
59 papers, 4.6k citations indexed

About

Morton S. Kahlenberg is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Morton S. Kahlenberg has authored 59 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 26 papers in Pathology and Forensic Medicine and 19 papers in Surgery. Recurrent topics in Morton S. Kahlenberg's work include Colorectal Cancer Treatments and Studies (18 papers), Genetic factors in colorectal cancer (18 papers) and Colorectal and Anal Carcinomas (9 papers). Morton S. Kahlenberg is often cited by papers focused on Colorectal Cancer Treatments and Studies (18 papers), Genetic factors in colorectal cancer (18 papers) and Colorectal and Anal Carcinomas (9 papers). Morton S. Kahlenberg collaborates with scholars based in United States, Canada and France. Morton S. Kahlenberg's co-authors include Norman Wolmark, Nicholas J. Petrelli, André Robidoux, Richard G. Margolese, Charles E. Geyer, Eleftherios P. Mamounas, Soonmyung Paik, Stewart Anderson, Harry D. Bear and Shaker R. Dakhil and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Morton S. Kahlenberg

59 papers receiving 4.5k citations

Hit Papers

Preoperative Chemotherapy: Updates of National Surgical A... 2006 2026 2012 2019 2008 2006 2009 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
    2008 1.3k citations Morton S. Kahlenberg et al. Journal of Clinical Oncology profile →
  2. Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27
    2006 722 citations Morton S. Kahlenberg et al. Journal of Clinical Oncology profile →
  3. Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03
    2009 690 citations Morton S. Kahlenberg, Nicholas J. Petrelli et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morton S. Kahlenberg United States 25 2.8k 2.4k 1.5k 1.4k 635 59 4.6k
Caroline Speers Canada 35 4.0k 1.5× 3.3k 1.4× 1.2k 0.8× 992 0.7× 1.5k 2.4× 140 6.3k
Toralf Reimer Germany 33 1.4k 0.5× 1.8k 0.8× 831 0.6× 1.1k 0.8× 464 0.7× 202 4.3k
Jennifer R. Bellon United States 35 3.5k 1.3× 4.2k 1.8× 1.9k 1.3× 1.0k 0.7× 1.6k 2.5× 164 6.8k
J. Michael Dixon United Kingdom 33 2.4k 0.9× 3.2k 1.3× 1.6k 1.1× 1.2k 0.8× 802 1.3× 82 5.0k
Kanwal Raghav United States 33 2.9k 1.0× 1.1k 0.5× 1.2k 0.8× 879 0.6× 1.2k 1.9× 203 4.3k
Aron Goldhirsch Italy 39 3.4k 1.2× 2.7k 1.2× 907 0.6× 496 0.4× 990 1.6× 119 5.4k
C.W. Elston United Kingdom 34 1.7k 0.6× 2.1k 0.9× 1.7k 1.2× 440 0.3× 387 0.6× 89 4.0k
Diana Crivellari Italy 37 3.3k 1.2× 2.1k 0.9× 736 0.5× 417 0.3× 1.2k 1.8× 152 4.9k
S. Kyriakides Italy 8 2.1k 0.8× 2.0k 0.8× 572 0.4× 389 0.3× 795 1.3× 13 3.6k
N V Dimitrov United States 15 3.2k 1.2× 4.3k 1.8× 2.1k 1.4× 953 0.7× 589 0.9× 21 6.0k

Countries citing papers authored by Morton S. Kahlenberg

Since Specialization
Citations

This map shows the geographic impact of Morton S. Kahlenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morton S. Kahlenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morton S. Kahlenberg more than expected).

Fields of papers citing papers by Morton S. Kahlenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morton S. Kahlenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morton S. Kahlenberg. The network helps show where Morton S. Kahlenberg may publish in the future.

Co-authorship network of co-authors of Morton S. Kahlenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Morton S. Kahlenberg. A scholar is included among the top collaborators of Morton S. Kahlenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morton S. Kahlenberg. Morton S. Kahlenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sinicrope, Frank A., Qian Shi, Fabienne Hermitte, et al.. (2020). Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer. JNCI Cancer Spectrum. 4(3). pkaa023–pkaa023. 32 indexed citations
2.
Singh, Preet Paul, Qian Shi, Nathan R. Foster, et al.. (2015). Relationship between metformin use and recurrence and survival in patients (pts) with resected stage III colon cancer (CC) receiving adjuvant chemotherapy: Results from NCCTG N0147 (Alliance).. Journal of Clinical Oncology. 33(15_suppl). 3531–3531. 4 indexed citations
3.
Shi, Qian, Frank A. Sinicrope, Daniel J. Sargent, et al.. (2015). Influence of molecular alterations on site-specific (ss) time to recurrence (TTR) following adjuvant therapy in resected colon cancer (CC) (Alliance Trial N0147).. Journal of Clinical Oncology. 33(15_suppl). 3590–3590. 2 indexed citations
4.
Sargent, Daniel J., T. C. Smyrk, Anthony F. Shields, et al.. (2010). ステージIII結腸癌を切除したKRAS野生型(WT)患者(pts)におけるセツキシマブ(Cmab)の有無にかかわらずmFOLFOX6アジュバント治療:NCCTG群間第3相試験NO147の結果. Journal of Clinical Oncology. 28. 959. 1 indexed citations
5.
Sharkey, Francis E., et al.. (2008). Actinomycotic Infection of the Abdominal Wall Mimicking a Malignant Neoplasm. Surgical Infections. 9(1). 85–89. 15 indexed citations
6.
Kahlenberg, Morton S., et al.. (2008). The Implications of Colorectal Cancer Molecular Biology in Clinical Practice. Surgical Oncology Clinics of North America. 17(2). 341–355. 5 indexed citations
7.
Krishnegowda, Naveen K., et al.. (2007). Flavonoid, Silibinin, Inhibits Proliferation and Promotes Cell-Cycle Arrest of Human Colon Cancer. Journal of Surgical Research. 143(1). 58–65. 156 indexed citations
8.
Liang, Sitai, Morton S. Kahlenberg, Dennis L. Rousseau, & Peter J. Hornsby. (2007). Neoplastic conversion of human colon smooth muscle cells: No requirement for telomerase. Molecular Carcinogenesis. 47(6). 478–484. 6 indexed citations
9.
Learn, Peter A., et al.. (2006). Compensatory Increases in Her-2/neu Activation in Response to EGFR Tyrosine Kinase Inhibition in Colon Cancer Cell Lines. Journal of Surgical Research. 136(2). 227–231. 13 indexed citations
10.
Welton, Mark L., Francis E. Sharkey, & Morton S. Kahlenberg. (2004). The etiology and epidemiology of anal cancer. Surgical Oncology Clinics of North America. 13(2). 263–275. 64 indexed citations
11.
Billingsley, Kevin G., Lawrence E. Stern, Andrew M. Lowy, Morton S. Kahlenberg, & Charles R. Thomas. (2004). Uncommon anal neoplasms. Surgical Oncology Clinics of North America. 13(2). 375–388. 12 indexed citations
12.
Pollock, Bradley H, et al.. (2004). Colorectal cancer in hispanics: A population at risk for earlier onset, advanced disease and decreased survival. Annals of Surgical Oncology. 11(S2). S108–S109. 4 indexed citations
13.
Yeh, I‐Tien, et al.. (2003). Pathologic Review of Atypical Hyperplasia Identified by Image-Guided Breast Needle Core Biopsy. Archives of Pathology & Laboratory Medicine. 127(1). 49–54. 53 indexed citations
14.
Kahlenberg, Morton S., et al.. (2003). Molecular prognostics in colorectal cancer. Surgical Oncology. 12(3). 173–186. 44 indexed citations
15.
Anderson, Garth R., Bruce M. Brenner, Helen Swede, et al.. (2001). Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR.. PubMed. 61(22). 8274–83. 51 indexed citations
16.
Kahlenberg, Morton S., John M. Kane, Peter M. Kanter, et al.. (2001). Hepatic Lymphatic Mapping: A Pilot Study for Porta Hepatis Lymph Node Identification. Cancer Investigation. 19(3). 256–260. 4 indexed citations
17.
Kahlenberg, Morton S., Daniel L. Stoler, Miguel A. Rodrı́guez-Bigas, et al.. (2000). p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma. Cancer. 88(8). 1814–1819. 37 indexed citations
18.
Kahlenberg, Morton S., Carmine Volpe, Donald Klippenstein, et al.. (1998). Clinicopathologic effects of cryotherapy on hepatic vessels and bile ducts in a porcine model. Annals of Surgical Oncology. 5(8). 713–718. 15 indexed citations
19.
Kahlenberg, Morton S., et al.. (1996). p53 Tumor Suppressor Gene Status and the Degree of Genomic Instability in Sporadic Colorectal Cancers. JNCI Journal of the National Cancer Institute. 88(22). 1665–1670. 38 indexed citations
20.
Rosenberg, Lynn, Morton S. Kahlenberg, Aaron I. Vinik, & William P. Duguid. (1996). Paracrine/autocrine regulation of pancreatic islet cell proliferation and differentiation in the hamster: studies using parabiosis.. PubMed. 19(1). 3–12. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Speers Breakdown of academic impact, for papers by Toralf Reimer Breakdown of academic impact, for papers by Jennifer R. Bellon Breakdown of academic impact, for papers by J. Michael Dixon Breakdown of academic impact, for papers by Kanwal Raghav Breakdown of academic impact, for papers by Aron Goldhirsch Breakdown of academic impact, for papers by C.W. Elston Breakdown of academic impact, for papers by Diana Crivellari Breakdown of academic impact, for papers by S. Kyriakides Breakdown of academic impact, for papers by N V Dimitrov
Rankless by CCL
2026